SCHEMBL2586742

SCHEMBL2586742

CC(c1ccccc1)c1ccccc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.46
KMT2A Q03164 1/20 0.44
TAAR1 Q96RJ0 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
CYP3A4 P08684 2/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
MAPT P10636 1/20 0.41
MTOR P42345 1/20 0.41
PMP22 Q01453 1/20 0.41
ADRA2A P08913 1/20 0.40
ADRA2C P18825 1/20 0.40
HIF1A Q16665 1/20 0.40
ALOX15 P16050 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10907895 1.00 TYR (0.46) TYRKMT2ATAAR1KDM4ELMNA
SCHEMBL15669918 0.87 CYP3A4 (0.36) TYRKMT2ATAAR1KDM4ELMNA
SCHEMBL732167 0.85 CYP3A4 (0.47) KMT2AKDM4ELMNACYP3A4ALDH1A1
SCHEMBL29765571 0.85 CYP3A4 (0.47) KMT2AKDM4ELMNACYP3A4ALDH1A1
SCHEMBL16756297 0.85 TYR (0.42) TYRKMT2ATAAR1KDM4ELMNA
SCHEMBL7914810 0.84 ADRB2 (0.47) KDM4ELMNACYP3A4ALDH1A1CYP2C9
SCHEMBL4658430 0.83 TYR (0.54) TYRKMT2ATAAR1KDM4ELMNA
SCHEMBL25195570 0.82 TYR (0.46) TYRKMT2ATAAR1KDM4ELMNA
SCHEMBL7922942 0.81 GAA (0.41) TYRKDM4ECYP3A4ALDH1A1MAPT
SCHEMBL10492576 0.80 TYR (0.48) TYRKMT2ATAAR1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701704-B2 Catalysts for (E)-selective olefin metathesis CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-07-11 US disclosed
US-9701704-B2 Catalysts for (E)-selective olefin metathesis CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-07-11 US disclosed
US-20170022231-A1 CATALYSTS FOR (E)-SELECTIVE OLEFIN METATHESIS CALIFORNIA INSTITUTE OF TECHNOLOGY 2017-01-26 US disclosed
US-20110274994-A1 Catalyst and Liquid Combination for a Thermally Regenerative Fuel Cell QUEEN'S UNIVERSITY AT KINGSTON (CA) 2011-11-10 US disclosed
EP-1249343-B1 Thermal initiator system using leuco dyes and polyhalogene compounds KODAK GRAPHIC COMM GMBH (DE) 2008-07-23 EP disclosed
EP-1478516-B1 IR-SENSITIVE COMPOSITION AND ON-PRESS DEVELOPABLE IR-SENSITIVE PRINTING PLATES KODAK POLYCHROME GRAPHICS LLC (US) 2006-04-12 EP disclosed
US-6864040-B2 Infrared radiation absorbers, radical producers of polyhaloalkyl -substituted compounds, polycarboxylic acids, and leuco dyes; printing plate precursors KODAK POLYCHROME GRAPHICS LLC (US) 2005-03-08 US disclosed
US-6846614-B2 Without requiring a preheat step or a separate development step KODAK POLYCHROME GRAPHICS LLC (US) 2005-01-25 US disclosed
EP-1478516-A1 ON-PRESS DEVELOPABLE IR SENSITIVE PRINTING PLATES Kodak Polychrome Graphics LLC (US) 2004-11-24 EP disclosed
US-20030157433-A1 Without requiring a preheat step or a separate development step KODAK (NEAR EAST) INC. 2003-08-21 US disclosed
EP-1249343-A2 Thermal initiator system using leuco dyes and polyhalogene compounds Kodak Polychrome Graphics GmbH (DE) 2002-10-16 EP disclosed
WO-1995011895-A1 N-BENZOYL-4-OXY/THIO-2-SUBSTITUTED PIPERIDINES AS SUBSTANCE-P RECEPTOR ANTAGONISTS CIBA-GEIGY AG (CH) 1995-05-04 WO disclosed
EP-0089530-B1 POLIMERIZATION PROCESS OF OPTICALLY ACTIVE POLYMER AND CATALYST THEREFOR DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1988-06-29 EP disclosed
EP-0089023-B1 STABILIZER SYSTEMS USEFUL IN LUBRICATING OILS AND METHOD FOR STABILIZING LUBRICATING OILS UNIROYAL, INC. (US) 1987-10-07 EP disclosed
US-4554334-A ANIONIC COMPLEX CATALYST DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1985-11-19 US disclosed
US-4478953-A COORDINATION, POLYMERIZATION CATALYST CONTAINING A LIGAND; ORGANOMETALLIC COMPOUND AND SECONDARY AMINE DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1984-10-23 US disclosed
US-4469609-A OXIDATION RESISTANCE UNIROYAL, INC. (US) 1984-09-04 US disclosed
EP-0089530-A2 Polimerization process of optically active polymer and catalyst therefor DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1983-09-28 EP disclosed
EP-0089023-A1 Stabilizer systems useful in lubricating oils and method for stabilizing lubricating oils UNIROYAL, INC. (US) 1983-09-21 EP disclosed
US-3965182-A Preparation of aniline from phenol and ammonia ETHYL CORPORATION (US) 1976-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170022231-A1 CATALYSTS FOR (E)-SELECTIVE OLEFIN METATHESIS COASY, FDFT1, SQLE TYR 702/4885KMT2A 1784/4885TAAR1 3263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.